On December 30, 2010, a box containing 15 prototype iPhone 4 cases had recently made its way from Hong Kong to David Albert. The cases were not handsome. Each held a small circuit board and a pair of electrodes, the sort of arrangement that tends to make an ordinary phone look as if it has acquired a minor but consequential hobby. Albert had plans to show the invention around the Consumer Electronics Show. First, he needed a video.
His nine-year-old son explained the YouTube part. Albert sat down, held the phone to the camera and began: “Let me show you something amazing.” In four minutes, he demonstrated how the case could turn an iPhone into a wireless ECG recorder. Then he uploaded the clip. Somewhere in the process, he checked a box that shared the video with his roughly 400 LinkedIn connections.
That stray click was the useful kind of accident. Messages arrived. The video traveled. Television producers called. Venture investors and prospective partners could see, immediately, what Albert had been trying to explain for years. A complicated clinical instrument had become an object that fit around the most familiar rectangle of the new century. The demonstration did not need animation, a swelling soundtrack or a futurist in a black turtleneck. It needed two hands and a phone.
“That was December 30, 2010. I remember it well!”David Albert, looking back at the original demo
The future first arrived with too many cables
The neatness of that video hid a long apprenticeship in untidy technology. Albert grew up in Oklahoma, graduated with honors from Harvard College and went to Duke for medicine, biomedical engineering and cardiovascular research. His first US patent, issued in 1983, covered a wrist-based pulse monitor. Two years later he started Corazonix, a University of Oklahoma spinout that put high-resolution ECG work on a personal computer. Arrhythmia Research Technology bought the company in 1990.
The pattern was already visible. Albert was interested in the signal, certainly, but also in its address. Why should useful data remain tethered to a particular machine in a particular room? In the mid-1990s he built an early version of a portable ECG. “Portable” was carrying a heavy load. The system required a clamshell handheld computer, a PCMCIA card, a modem, a mobile phone and a cable to persuade the pieces to speak to one another. Albert later called it a Rube Goldberg concoction. It worked. It was also a persuasive argument for waiting.
The disappearing pile of hardware
Waiting did not mean standing still. In 1995, Albert founded Data Critical, which built wireless systems for moving clinical information. The company partnered with established medical and technology businesses, went public in 1999 and was acquired by GE Healthcare in 2001. The date of the sale, September 11, is one of those factual details too strange for a screenwriter. Albert stayed and became chief scientist of GE Cardiology. In 2004, he left to start again.
His next work included InnovAlarm and Lifetone Technology, ventures concerned with safety alarms. The subject changed; his obsession with signals that must reach people did not. By 2007 the missing platform for his older ECG idea had appeared. The iPhone supplied a high-quality screen, a computer, a network connection and, soon, an app store. The pieces that once filled a small travel bag had collapsed into something millions of people already carried.
A company built around the demonstration
In 2009 Albert began developing the smartphone ECG concept with Bruce Satchwell and Kim Barnett, longtime collaborators in Australia. AliveCor emerged in 2011 to commercialize it. The early product was a single-lead recorder built into an iPhone case. It received FDA clearance in 2012. The object would change shape over time, separating from the phone and becoming a small device in its own right, but the original proposition remained legible: make the measurement easy to take, simple to transmit and useful beyond the room where it was recorded.
Albert has said the company began with a vision centered on ease of use, experience and cost, with the technology almost in the back seat. This is a notable admission from someone with 80 issued US patents. Inventors are supposed to fall in love with mechanisms. Albert's more durable affection appears to be for removal. One fewer cable. One fewer special-purpose screen. One less reason that useful information should wait.
There is a temptation to treat the 2010 video as a lightning strike. It was better understood as a match applied to material stacked over three decades. Albert already knew how to patent an invention, recruit engineers, form a company, work with regulators, partner with larger manufacturers and survive an acquisition. The clip made the product visible. The preceding companies made it plausible.
He also had the founder's useful willingness to look faintly ridiculous in public. Albert recalls launching his first company as “the dumbest thing” he had done. Mentors reassured him that he could return to medicine if it failed. He reduced the arrangement to a joke: “Plan B is MD.” Four companies and several exits later, the backup plan remains conspicuously unused.
Hardware earns its name
Albert likes to observe that the root word of hardware is hard. The line works because it is obvious and because founders keep forgetting it. A physical device must be designed for hands, not slides. It must emerge from factories in reliable quantities. A medical device adds evidence, clearances and the responsibility of being believed. The distance between a prototype that looks magical on video and a product that behaves predictably in the world is measured in years of unphotogenic labor.
AliveCor's path shows the accumulation. The original phone case became KardiaMobile. More leads followed. Software began interpreting recordings, organizing them and connecting the data to professional workflows. The platform expanded internationally. In 2024, the company received FDA clearance for Kardia 12L, a handheld system that compresses the familiar 12-lead process into a portable, single-cable format. Further clearances arrived in January 2026, and a European launch followed in April.
Corazonix starts with a PC-based high-resolution ECG.
Data Critical begins moving clinical information wirelessly.
Fifteen prototype iPhone cases and a four-minute video.
The smartphone ECG receives FDA clearance.
Kardia 12L expands in the United States and Europe.
The progression from one lead to twelve has a pleasing circularity. Albert spent the beginning of his career trying to liberate clinical signals from large systems. His company is now bringing a compact device back into professional settings, this time carrying the benefits of software, networking and machine analysis that the old machines lacked. Consumer and clinical technology, once treated as separate species, are learning to share a habitat.
“I don't play golf.”David Albert, on what leaves him time to invent
The bow tie is part of the instrument
Albert is an unusually recognizable figure for a medical-device founder. The checked jackets, translucent spectacles and bow ties help. So does the pleasure he takes in showing things. A demonstration by Albert has the genial energy of a favorite professor who has smuggled a particularly good object into class. The polish is real, but enthusiasm keeps escaping around the edges.
He has lectured in entrepreneurship programs at MIT Sloan and the University of Oklahoma, and he continues to appear in interviews and product demonstrations. His official biography lists more than 100 scientific abstracts and publications alongside the patents. Those two records explain each other. Albert belongs to the tradition of builders who need both the bench and the audience, the mechanism and the argument for why it should exist.
His current language has shifted toward artificial intelligence, but the basic test remains practical. Algorithms should extract useful meaning from signals while human expertise retains an essential role. In his account, the ambition is not to decorate devices with fashionable software. It is to turn recordings into information that can move through ordinary life without losing clinical seriousness.
That is also why the original video still matters. Its charm does not come from nostalgia for the iPhone 4, a device now thick enough to look almost upholstered. It comes from watching a future become obvious in someone's hands. Albert had carried the concept through wrist monitors, personal computers, modems and mobile phones. At last, the supporting technology stopped arguing with him.
He once said it did not matter whether the world was ready. The career suggests a slight amendment. Readiness matters enormously; it simply does not arrive on schedule. The inventor's work is to notice when the stubborn old idea and the newly available tool finally recognize each other. Then, if necessary, ask a child how to upload the video.